Hallucinations in AI: How GSK is addressing a critical problem in drug development
Hallucinations are a persistent problem in healthcare. Here's how GSK is using test-time compute scaling to improve its gen AI systems.
Hosted on MSN1d
If Even 0.001 Percent of an AI's Training Data Is Misinformation, the Whole Thing Becomes Compromised, Scientists Find
It's no secret that large language models (LLMs) like the ones that power popular chatbots like ChatGPT are far from ...